C

Crossject
ALCJ

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
€42.03M
EV
€56.06M
Shares Outstanding
47.76M
Beta
0.83

Wall Street View

Analyst Rating
BUY
Analyst Target Price
€4.30
P/E 2025E
1.70x
P/Revenue 2025E
0.79x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Crossject Société Anonyme

gainify

C

Crossject Société Anonyme

ALCJ

Crossject Société Anonyme develops needle-free injection systems in France. The company develops ZENEO, a needle-free device for patient-side management disorders self-injectables. Its product pipeline includes Midazolam for epileptic seizure; Naloxone for opioid over...

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Alexandre, Patrick

Employees

106

IPO Date

2014-02-20

Headquarters

6 Rue Pauline Kergomard, Dijon, Burgundy, 21000, France

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved